Exuperio Díez-Tejedor
Exuperio Díez-Tejedor is an expert in Neurology at Hospital Universitario La Paz (Spain). As of March 2026, ScienceLeadR ranks Exuperio Díez-Tejedor in the top 1% of experts worldwide for Cerebrovascular Disorders. Exuperio Díez-Tejedor has authored 380 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 1 of them ongoing. SLR score: 1,168 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Immunology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1990 - 2026
Number : 380
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Immune Checkpoint Signatures Reveal Stage-Specific Biomarkers for High-Activity Multiple Sclerosis. PMID 41752043 — cells, sclerosis, multiple sclerosis, killer cells, natural, biomarkers, therapeutics, memory | Int J Mol Sci | 2026 | 0 |
| Infection-driven proteomic signatures in immune cell-derived extracellular vesicles reflect hemorrhagic stroke outcome. PMID 41345658 — cells, extracellular vesicles, stroke, hemorrhagic stroke, infections | J Neuroinflammation | 2025 | 0 |
| Extracellular Vesicles from Poor-Outcome Intracerebral Hemorrhage Patients Reveal Limited Reparative Potential in a Preclinical Model. PMID 41226682 — extracellular vesicles, cerebral hemorrhage, hemorrhage, recycling, therapeutics | Int J Mol Sci | 2025 | 0 |
| Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis. PMID 41190076 — cells, sclerosis, multiple sclerosis, biomarkers, therapeutics, immune checkpoint proteins, non-responder | Front Immunol | 2025 | 0 |
| Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes. PMID 41071973 — cells, extracellular vesicles, blood, neoplasms, paraneoplastic syndromes, nervous system, biomarkers, biomarkers, tumor, b-lymphocytes | Neurol Neuroimmunol Neuroinflamm | 2025 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke NCT05691244 — safety, saline solution, ischemic stroke, stroke, endothelins, pharmaceutical preparations, receptor, endothelin b, solutions, pharmaceutical vehicles | Phase 3 | Recruiting | 2025 |
LeadR Networks
Main global connection map